<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0034-7418</journal-id>
<journal-title><![CDATA[Revista Colombiana de Ciencias Químico - Farmacéuticas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. colomb. cienc. quim. farm.]]></abbrev-journal-title>
<issn>0034-7418</issn>
<publisher>
<publisher-name><![CDATA[Departamento de Farmácia, Facultad de Ciencias, Universidade Nacional da Colombia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0034-74182021000200439</article-id>
<article-id pub-id-type="doi">10.15446/rcciquifa.v50n2.97919</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Síntesis en fase sólida de un neuropéptido cosmecéutico y su microencapsulación en un sistema liposomal]]></article-title>
<article-title xml:lang="en"><![CDATA[Solid phase synthesis of a cosmeceutical neuropeptide and its microencapsulation in a liposomal system]]></article-title>
<article-title xml:lang="pt"><![CDATA[Síntese de fase sólida de um neuropeptídeo cosmecêutico e sua microencapsulação em um sistema lipossomal]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sandoval A.]]></surname>
<given-names><![CDATA[J. Andrés]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rosas P.]]></surname>
<given-names><![CDATA[Jaiver E.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional de Colombia Facultad de Ciencias Departamento de Farmacia]]></institution>
<addr-line><![CDATA[Bogotá D.C.]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2021</year>
</pub-date>
<volume>50</volume>
<numero>2</numero>
<fpage>439</fpage>
<lpage>456</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0034-74182021000200439&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0034-74182021000200439&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0034-74182021000200439&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: Actualmente los péptidos sintéticos se han constituido en una novedosa alternativa para el tratamiento de la piel envejecida. Acetilhexapéptido-3 (Ac-EEMQRR-NH2) ha sido utilizado para inducir reducción de líneas de expresión de manera análoga a la toxina botulínica, pero sin efectos tóxicos.  Objetivo: Sintetizar el acetilhexapéptido-3 y desarrollar un sistema liposomal para su encapsulación y favorecer su paso a través de una membrana modelo.  Metodología: El péptido fue obtenido mediante síntesis en fase sólida (SFS) empleando la estrategia Fmoc/tBu, fue purificado y plenamente caracterizado. El sistema liposomal con acetilhexapéptido-3 encapsulado fue desarrollado mediante la formación de una emulsión con posterior inversión de fase por evaporación del solvente orgánico. Los sistemas fueron caracterizados en su tamaño, potencial zeta, eficiencia de encapsulación del neuropéptido y de manera preliminar se realizó un estudio de permeabilidad ex vivo.  Resultados: Es posible sintetizar péptidos cortos con alto grado de pureza y buen rendimiento, utilizando la metodología de SFS Fmoc/tBu. De acuerdo con la caracterización, el sistema liposomal adelantado sugiere una buena estrategia para la encapsulación del acetilhexapéptido-3 y su potencial aplicación en el desarrollo un novedoso producto cosmecéutico.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY  Introduction: Currently synthetic peptides have become a novel alternative for the treatment of aging skin. Acetylhexapeptide-3 (Ac-EEMQRR-NH2) has been used to induce reduction of expression lines in a manner analogous to botulinum toxin, but without toxic effects.  Aim: To synthesize acetylhexapeptide-3 and to develop a lipo-somal system for its encapsulation and favor its passage through a model membrane.  Methodology: The peptide was obtained by solid phase synthesis (SFS) using the Fmoc / tBu strategy, it was purified and fully characterized. The liposomal system with encapsulated acetylhexapeptide-3 was developed by forming an emulsion with subsequent phase inversion by evaporation of the organic solvent. The systems were characterized in their size, zeta potential, neuropeptide encapsulation efficiency and a preliminary ex vivo permeability study was carried out.  Results: It is possible to synthesize short peptides with a high degree of purity and good yield, using the SFS Fmoc / tBu methodology. According to the characterization, the advanced liposomal system suggests a good strategy for the encapsulation of acetylhexapeptide-3 and its potential application in the development of a novel cosmeceutical product.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução: Atualmente os peptídeos sintéticos têm se tornado uma nova alternativa para o tratamento do envelhecimento cutâneo. O acetilhexapeptídeo-3 (Ac-EEMQR-R-NH2) tem sido usado para induzir a redução das linhas de expressão de maneira análoga à toxina botulínica, mas sem efeitos tóxicos.  Objetivo: Sintetizar acetilhe-xapeptídeo-3 e desenvolver um sistema lipossomal para seu encapsulamento e favorecer sua passagem por uma membrana modelo.  Metodologia: O peptídeo foi obtido por síntese em fase sólida (SFS) utilizando a estratégia Fmoc / tBu, foi purificado e totalmente caracterizado. O sistema lipossomal com acetilhexapeptídeo-3 encapsulado foi desenvolvido pela formação de uma emulsão com subsequente inversão de fase por evaporação do solvente orgânico. Os sistemas foram caracterizados quanto ao tamanho, potencial zeta, eficiência de encapsulação de neuropeptídeos e um estudo preliminar de permeabilidade ex vivo foi realizado.  Resultados: É possível sintetizar peptídeos curtos com alto grau de pureza e bom rendimento, utilizando a metodologia SFS Fmoc / tBu. De acordo com a caracterização, o sistema lipossomal avançado sugere uma boa estratégia para a encapsulação do acetilhexapeptídeo-3 e seu potencial aplicação no desenvolvimento de um novo produto cosmecêutico.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[péptidos sintéticos]]></kwd>
<kwd lng="es"><![CDATA[liposomas]]></kwd>
<kwd lng="es"><![CDATA[microencapsulación]]></kwd>
<kwd lng="en"><![CDATA[synthetic peptides]]></kwd>
<kwd lng="en"><![CDATA[liposomes]]></kwd>
<kwd lng="en"><![CDATA[microencapsulation]]></kwd>
<kwd lng="pt"><![CDATA[peptídeos sintéticos]]></kwd>
<kwd lng="pt"><![CDATA[lipossomas]]></kwd>
<kwd lng="pt"><![CDATA[microencapsulação]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Korhonen]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Pihlanto]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bioactive Peptides: Production and functionality]]></article-title>
<source><![CDATA[Int. Dairy J]]></source>
<year>2006</year>
<numero>16</numero>
<issue>16</issue>
<page-range>945-60</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lau]]></surname>
<given-names><![CDATA[J.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Dunn]]></surname>
<given-names><![CDATA[M.K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Therapeutic peptides: Historical perspectives, current development trends, and future directions]]></article-title>
<source><![CDATA[Bioorg. Med. Chem]]></source>
<year>2018</year>
<volume>26</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>27002707</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fields]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Falla]]></surname>
<given-names><![CDATA[T.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodan]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bush]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bioactive peptides: signaling the future]]></article-title>
<source><![CDATA[J. Cosmet. Dermatol]]></source>
<year>2009</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>8-13</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Xiao]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pan]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Huo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: A randomized, placebo-controlled study]]></article-title>
<source><![CDATA[Am. J. Clin. Dermatol]]></source>
<year>2013</year>
<volume>14</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>147-53</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blanes-Mira]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Clemente]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Jodas]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gil]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Ballester]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ponsati]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A synthetic hexapeptide (Argireline) with antiwrinkle activity]]></article-title>
<source><![CDATA[Int. J. Cos-met. Sci]]></source>
<year>2002</year>
<volume>24</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>303-10</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carpino]]></surname>
<given-names><![CDATA[L.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[G.Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[9-Fluorenylmethoxycarbonyl function, a new base-sensitive amino-protecting group]]></article-title>
<source><![CDATA[J. Am. Chem. Soc]]></source>
<year>1970</year>
<numero>92</numero>
<issue>92</issue>
<page-range>5748-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guzman]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Barberis]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Illanes]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Peptide synthesis: Chemical or enzymatic]]></article-title>
<source><![CDATA[Electr. J. Biotechnol]]></source>
<year>2007</year>
<volume>10</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>279-314</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Craik]]></surname>
<given-names><![CDATA[D.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Fairlie]]></surname>
<given-names><![CDATA[D.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Liras]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Price]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The future of peptide-based drugs]]></article-title>
<source><![CDATA[Chem. Biol. Drug Des]]></source>
<year>2013</year>
<volume>81</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>136-47</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cholewinski]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Luickel]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Horn]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Degradation pathways, analytical characterization and formulation strategies of a peptide and a protein calcitonine and human growth hormone in comparison]]></article-title>
<source><![CDATA[Pharm. Acta Helv]]></source>
<year>1996</year>
<volume>71</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>405-19</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parkins]]></surname>
<given-names><![CDATA[D.U.]]></given-names>
</name>
<name>
<surname><![CDATA[Lashmar]]></surname>
<given-names><![CDATA[U.T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The formulation of biopharmaceutical products]]></article-title>
<source><![CDATA[Pharm. Sci. Technol. Today]]></source>
<year>2000</year>
<volume>3</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>129-37</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dai]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Microencapsulation peptide and protein drugs delivery system]]></article-title>
<source><![CDATA[Colloids Surf. B, Biointerfaces]]></source>
<year>2005</year>
<volume>41</volume>
<numero>2-3</numero>
<issue>2-3</issue>
<page-range>117-20</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosas]]></surname>
<given-names><![CDATA[J.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[R.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Gascón]]></surname>
<given-names><![CDATA[A.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Igartua]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Guzman]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Patarroyo]]></surname>
<given-names><![CDATA[M.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Pedraz]]></surname>
<given-names><![CDATA[J.L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biodegradable PLGA microespheres as a delivery system for malaria synthetic peptide SPf66]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2001</year>
<volume>19</volume>
<page-range>4445-51</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jorgensen]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Moeller]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Weert]]></surname>
<given-names><![CDATA[M. Van de]]></given-names>
</name>
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Frokjaer]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preparing and evaluating delivery systems for proteins]]></article-title>
<source><![CDATA[Eur. J. Pharm. Sci]]></source>
<year>2006</year>
<volume>29</volume>
<numero>3-4</numero>
<issue>3-4</issue>
<page-range>174-82</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Allen]]></surname>
<given-names><![CDATA[T.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Cullis]]></surname>
<given-names><![CDATA[P.R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Liposomal drug delivery systems: from concept to clinical applications]]></article-title>
<source><![CDATA[Adv. DrugDeliv. Rev]]></source>
<year>2013</year>
<volume>65</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>36-48</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oliveira-Eloy]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Souza]]></surname>
<given-names><![CDATA[M. Claro de]]></given-names>
</name>
<name>
<surname><![CDATA[Petrilli]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Palma]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Barcellos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[R.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Maldonado-Marchetti]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery]]></article-title>
<source><![CDATA[Colloids Surf. B, Biointerfaces]]></source>
<year>2014</year>
<numero>123</numero>
<issue>123</issue>
<page-range>345-63</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patravale]]></surname>
<given-names><![CDATA[V.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Mandawgade]]></surname>
<given-names><![CDATA[S.D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Novel cosmetic delivery systems: an application update]]></article-title>
<source><![CDATA[Int. J. Cosmet. Sci]]></source>
<year>2008</year>
<volume>30</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>19-33</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vergel-Galeano]]></surname>
<given-names><![CDATA[C.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera-Monroy]]></surname>
<given-names><![CDATA[Z.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Rosas-Pérez]]></surname>
<given-names><![CDATA[J.E.]]></given-names>
</name>
<name>
<surname><![CDATA[García-Castañeda]]></surname>
<given-names><![CDATA[J.E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficient synthesis of peptides with 4-methylpiperidine as Fmoc removal reagent by solid phase synthesis]]></article-title>
<source><![CDATA[J. Mex. Chem. Soc]]></source>
<year>2014</year>
<volume>58</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>386-92</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaiser]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Colescott]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bossinger]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cook]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides]]></article-title>
<source><![CDATA[Anal. Biochem]]></source>
<year>1970</year>
<volume>34</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>595-8</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Szoka]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Jr.]]></surname>
<given-names><![CDATA[D. Papahadjopoulos]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation]]></article-title>
<source><![CDATA[Proc. Natl. Acad. Sci. USA]]></source>
<year>1978</year>
<volume>75</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>4194-8</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maestrelli]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[González-Rodríguez]]></surname>
<given-names><![CDATA[M.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Rabasco]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Mura]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery]]></article-title>
<source><![CDATA[Int. J. Pharm]]></source>
<year>2006</year>
<volume>312</volume>
<numero>1-2</numero>
<issue>1-2</issue>
<page-range>53-60</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cevc]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lipid vesicles and other colloids as drug carriers on the skin]]></article-title>
<source><![CDATA[Adv. Drug Deliv. Rev]]></source>
<year>2004</year>
<volume>56</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>675-711</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gillet]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lecomte]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Hubert]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ducat]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Evrard]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Piel]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Skin penetration behaviour of liposomes as a function of their composition]]></article-title>
<source><![CDATA[Eur. J. Pharm. Biopharm]]></source>
<year>2011</year>
<volume>79</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>43-53</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zheng]]></surname>
<given-names><![CDATA[W.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Fang]]></surname>
<given-names><![CDATA[X.Q.]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[L.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[Y.J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preparation and quality assessment of itraconazole transfersomes]]></article-title>
<source><![CDATA[Int. J. Pharm]]></source>
<year>2012</year>
<volume>436</volume>
<numero>1-2</numero>
<issue>1-2</issue>
<page-range>291-8</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hinkelmann]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kempthorne]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<source><![CDATA[Desing and Analysis of Experiments]]></source>
<year>2007</year>
<volume>1</volume>
<edition>2</edition>
<publisher-loc><![CDATA[New Jersey (NJ) ]]></publisher-loc>
<publisher-name><![CDATA[Wiley]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kuehl]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Diseño de experimentos]]></source>
<year>2001</year>
<edition>2</edition>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Thomson Learning]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="">
<collab>OECD</collab>
<article-title xml:lang=""><![CDATA[Guideline for the testing of chemicals]]></article-title>
<source><![CDATA[Test N. ° 428 Skin Absorption: In vitro Method]]></source>
<year>2004</year>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Draelos]]></surname>
<given-names><![CDATA[Z.D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The cosmeceutical realm]]></article-title>
<source><![CDATA[Clin. Dermatol]]></source>
<year>2008</year>
<volume>26</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>627-32</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malheiros]]></surname>
<given-names><![CDATA[P. da Silva]]></given-names>
</name>
<name>
<surname><![CDATA[Micheletto]]></surname>
<given-names><![CDATA[Y.M.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Silveira]]></surname>
<given-names><![CDATA[N.P. da]]></given-names>
</name>
<name>
<surname><![CDATA[Brandelli]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and characterization of phosphatidylcholine nanovesicles containing the antimicrobial peptide nisin]]></article-title>
<source><![CDATA[Food Res. Int]]></source>
<year>2010</year>
<volume>43</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1198-203</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ghodeswar]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gajbhiye]]></surname>
<given-names><![CDATA[K.R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transdermal delivery of anti-fungal drug using elastic liposomes]]></article-title>
<source><![CDATA[Int. J. Adv. Pharm. Sci]]></source>
<year>2010</year>
<volume>1</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>369-74</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cevc]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Vierl]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanotechnology and the transdermal route a state of the art review and critical appraisal]]></article-title>
<source><![CDATA[J. Control. Release]]></source>
<year>2010</year>
<volume>141</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>277-99</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kale]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Suruse]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Malhotra]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Raut]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of size reduction techniques on doxorubicin hydrochloride loaded liposomes]]></article-title>
<source><![CDATA[Int. J. Biol. Pharm. Res]]></source>
<year>2012</year>
<volume>3</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>308-16</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hunter]]></surname>
<given-names><![CDATA[R.J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Zeta Potential in Colloids Science. Principles and Applications]]></source>
<year>1988</year>
<edition>8</edition>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Academic Press Inc.]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
